MEHMET KAAN KIRALİ, Atakan ERKILINÇ, Ahmet Erdal TAŞCI, Mustafa Mert ÖZGÜR, Gonca GEÇMEN, Ece ALTINAY, Halide OĞUŞ, Mustafa VAYVADA

Follow-up strategy with long-term veno-venous extracorporeal membrane oxygenation support for complicated severe acute respiratory distress related to COVID-19 and recovery of the lungs

Novel coronavirus-2019 (COVID-19) pandemic has affected all over the world, leading to viral pneumonia-complicating severe acute respiratory distress syndrome and death. Although there is no proven definitive treatment yet, physicians use some assistive methods based on the previous epidemic viral acute respiratory distress syndrome experiences. Extracorporeal membrane oxygenation is one of them. In this report, we present one of the longest survived extracorporeal membrane oxygenation case (71 days) with COVID-19 infection and the pathology of the infected lung, with our veno-venous extracorporeal membrane oxygenation strategy.

COVID-19 enfeksiyonuna bağlı komplike şiddetli akut respiratuvar distres sendromunda uzun dönem venovenöz ekstrakorporeal membran oksijenasyon desteği ile takip stratejisi ve akciğerlerin iyileşme süreci

Yeni koronavirüs-2019 (COVID-19) pandemisi, viral pnömoniye bağlı şiddetli akut respiratuvar distres sendromu ve ölüme yol açarak, tüm dünyayı etkisi altına almıştır. Henüz kanıtlanmış kesin bir tedavi olmamasına rağmen, hekimler önceki epidemik viral akut respiratuvar distres sendromu deneyimlerinden faydalanarak, bazı yardımcı yöntemler kullanmaktadır. Ekstrakorporeal membran oksijenasyonu da bunlardan biridir. Bu makalede, COVID-19 enfeksiyonu ile hayatta kalan en uzun ekstrakorporeal membran oksijenasyonu olgularından biri (71 gün) ve enfekte akciğer patolojisi, veno-venöz ekstrakorporeal membran oksijenasyon stratejimiz ile birlikte sunuldu. Anahtar sözcükler: Akut respiratuvar distres sendromu, COVID-19, COVID-19 patolojisi, ekstrakorporeal membran oksijenasyonu, venovenöz.

PDF

___

1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054-62.
2. Navas-Blanco JR, Dudaryk R. Management of respiratory distress syndrome due to COVID-19 infection. BMC Anesthesiol 2020;20:177.
3. Baksh M, Ravat V, Zaidi A, Patel RS. A systematic review of cases of acute respiratory distress syndrome in the Coronavirus disease 2019 pandemic. Cureus 2020;12:e8188.
4. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: A global literature survey. Crit Care 2020;24:516.
5. Cho HJ, Heinsar S, Jeong IS, Shekar K, Li Bassi G, Jung JS, et al. ECMO use in COVID-19: Lessons from past respiratory virus outbreaks-a narrative review. Crit Care 2020;24:301.
6. Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020;396:1071-8.
7. Lentz S, Roginski MA, Montrief T, Ramzy M, Gottlieb M, Long B. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. Am J Emerg Med 2020;38:2194-202.
8. Fiore A, de Roux Q, Daami N, Clariot S, Folliguet T, Taccone FS, et al. Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation. J Infect 2020;81:e59-e60.